These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7557102)

  • 1. Subclinical Addison's disease: a cause of persistent abnormalities in transaminase values.
    Boulton R; Hamilton MI; Dhillon AP; Kinloch JD; Burroughs AK
    Gastroenterology; 1995 Oct; 109(4):1324-7. PubMed ID: 7557102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver involvement in Addison's disease.
    Olsson RG; Lindgren A; Zettergren L
    Am J Gastroenterol; 1990 Apr; 85(4):435-8. PubMed ID: 2327387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we consider Addison's disease in the differential diagnosis of persistent hypertransaminasemia? A case report.
    Anagnostis P; Athyros VG; Vasiliadis T; Griva T; Patsiaoura K; Karagiannis A
    Acta Gastroenterol Belg; 2011 Mar; 74(1):95-6. PubMed ID: 21563662
    [No Abstract]   [Full Text] [Related]  

  • 4. Addison's disease: a rare cause of hypertransaminasaemia.
    Ersan O; Demirezer B
    Dig Dis Sci; 2008 Dec; 53(12):3269-71. PubMed ID: 18465237
    [No Abstract]   [Full Text] [Related]  

  • 5. [Addison's disease and hepatic biochemical disorders. Retrospective analysis].
    Domper Bardají F; Yebra Bango M; Brito Sanfiel MA; Lucas Morante T
    Rev Clin Esp; 1998 Jul; 198(7):488. PubMed ID: 9737168
    [No Abstract]   [Full Text] [Related]  

  • 6. [Addison's disease as a rare cause of chronically elevated liver enzymes].
    Gurakuqi GC; Stadlbauer V; Stepan V; Warnkross H; Trauner M
    Z Gastroenterol; 2006 Feb; 44(2):179-83. PubMed ID: 16456760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addison's disease and hypertransaminasemia.
    Kalambokis G; Milionis HJ
    Expert Rev Endocrinol Metab; 2009 May; 4(3):251-261. PubMed ID: 30743790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertransaminasaemia and Addison's disease.
    Castiella A; Etxeberria X; Ganzarain J; Aramburu V
    Eur J Gastroenterol Hepatol; 1998 Oct; 10(10):891-2. PubMed ID: 9831414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease.
    Uibo R; Aavik E; Peterson P; Perheentupa J; Aranko S; Pelkonen R; Krohn KJ
    J Clin Endocrinol Metab; 1994 Feb; 78(2):323-8. PubMed ID: 8106620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained hypertransaminasaemia: clue to diagnosis of Addison's disease.
    Milionis HJ; Dimos GA; Tsiara S; Tsatsoulis A; Tsianos EV; Elisaf MS
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1285-6. PubMed ID: 12439129
    [No Abstract]   [Full Text] [Related]  

  • 11. Addison's disease: the potentially life-threatening tan.
    Erickson QL; Faleski EJ; Koops MK; Elston DM
    Cutis; 2000 Jul; 66(1):72-4. PubMed ID: 10916697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.
    Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Greggio NA; Sanzari M; Tedesco F; Pedini B; Boscaro M; Presotto F
    J Clin Endocrinol Metab; 1997 Mar; 82(3):932-8. PubMed ID: 9062509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver involvement and abnormal iron variables in undiagnosed Addison's disease.
    Rizvi AA; Kerrick JG
    Endocr Pract; 2001; 7(3):184-8. PubMed ID: 11421565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Addison's disease in the framework of poly-glandular autoimmune syndromes: 3 case reports].
    Senti S; Müller J
    Schweiz Med Wochenschr; 1992 Feb; 122(5):147-52. PubMed ID: 1738820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexplained hypertransaminasaemia: a clue to the diagnosis of Addison's disease.
    Roblin X; Phelip JM; Milionis HJ
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):929; author reply 929-30. PubMed ID: 12867806
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between serum transaminase activities and fatty liver in children with simple obesity.
    Noguchi H; Tazawa Y; Nishinomiya F; Takada G
    Acta Paediatr Jpn; 1995 Oct; 37(5):621-5. PubMed ID: 8533591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in transaminase before and after tonsillectomy].
    Chiba Y
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Jul; 96(7):1094-8. PubMed ID: 8366404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Addison's disease and fetal growth retardation. A case report.
    O'Shaughnessy RW; Hackett KJ
    J Reprod Med; 1984 Oct; 29(10):752-6. PubMed ID: 6512785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare cause of elevated liver enzymes: Addison's disease.
    Çuhaci N; Demırezer A; Özdemır D; Ersoy R; Ersoy O; Çakir B
    Turk J Gastroenterol; 2013; 24(1):76-7. PubMed ID: 23794352
    [No Abstract]   [Full Text] [Related]  

  • 20. Associated autoimmunity in Addison's disease.
    Zelissen PM; Bast EJ; Croughs RJ
    J Autoimmun; 1995 Feb; 8(1):121-30. PubMed ID: 7734032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.